Clinical trials
Recruiting Gaucher Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Minnesota | 3 |
| Paul Szabolcs | 2 |
| University of California, San Francisco | 2 |
| Duke University | 1 |
| Genzyme, a Sanofi Company | 1 |
| Shire | 1 |
| Spur Therapeutics | 1 |
| UNC Lineberger Comprehensive Cancer Center | 1 |
| University of Pittsburgh | 1 |
| Yale University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gaucher Disease | 15 |
| Sudden Infant Death | 4 |
| Anemia, Sickle Cell | 3 |
| Leukodystrophy, Globoid Cell | 3 |
| Mucopolysaccharidosis I | 3 |
| Mucopolysaccharidosis IV | 3 |
| Osteopetrosis | 3 |
| alpha-Mannosidosis | 3 |
| beta-Thalassemia | 3 |
| Adrenoleukodystrophy | 2 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.